Piper Sandler Reiterates Overweight Rating on Allstate (ALL)

Go back to Piper Sandler Reiterates Overweight Rating on Allstate (ALL)

CFRA Downgrades Allstate (ALL) to Hold

August 14, 2024 2:39 PM EDT

CFRA analyst Catherine Seifert downgraded Allstate (NYSE: ALL) from Buy to Hold with a price target of $200.00.

The analyst comments "We keep our 12-month target of $200, valuing ALL shares at 11.4x our 2025 operating EPS estimate of $17.50, versus the one-year average forward multiple of... More